Neovacs S.A. (ALNEV.PA)

EUR 0.03

(-13.08%)

Gross Profit Summary of Neovacs S.A.

  • Neovacs S.A.'s latest annual gross profit in 2023 was 29.31 Thousand EUR , down -96.66% from previous year.
  • Neovacs S.A.'s latest quarterly gross profit in 2024 Q2 was -3.11 Million EUR , down 0.0% from previous quarter.
  • Neovacs S.A. reported a annual gross profit of -3.43 Million EUR in annual gross profit 2022, up 2.36% from previous year.
  • Neovacs S.A. reported a annual gross profit of -3.51 Million EUR in annual gross profit 2021, down -95.98% from previous year.
  • Neovacs S.A. reported a quarterly gross profit of -3.61 Million EUR for 2023 Q2, down 0.0% from previous quarter.
  • Neovacs S.A. reported a quarterly gross profit of -6.75 Million EUR for 2023 FY, down -96.66% from previous quarter.

Annual Gross Profit Chart of Neovacs S.A. (2023 - 2009)

Historical Annual Gross Profit of Neovacs S.A. (2023 - 2009)

Year Gross Profit Gross Profit Growth
2023 29.31 Thousand EUR -96.66%
2022 -3.43 Million EUR 2.36%
2021 -3.51 Million EUR -95.98%
2020 -1.79 Million EUR -4708.59%
2019 38.94 Thousand EUR 100.42%
2018 -9.35 Million EUR -20417.45%
2017 -45.57 Thousand EUR 99.68%
2016 -14.32 Million EUR -65.19%
2015 -8.67 Million EUR -13.49%
2014 -7.64 Million EUR -1375.85%
2013 -517.7 Thousand EUR -100.7%
2012 -257.94 Thousand EUR 44.45%
2011 -464.33 Thousand EUR 93.73%
2010 -7.4 Million EUR -14.33%
2009 -6.47 Million EUR 0.0%

Peer Gross Profit Comparison of Neovacs S.A.

Name Gross Profit Gross Profit Difference
ABIONYX Pharma SA 618 Thousand EUR 95.257%
ABIVAX Société Anonyme 3.91 Million EUR 99.251%
Adocia SA 1.38 Million EUR 97.883%
Aelis Farma SA 12.35 Million EUR 99.763%
Biophytis S.A. -803 Thousand EUR 103.651%
Advicenne S.A. 1.42 Million EUR 97.944%
genOway Société anonyme 20.1 Million EUR 99.854%
IntegraGen SA 5.01 Million EUR 99.416%
Medesis Pharma S.A. -2.66 Million EUR 101.1%
NFL Biosciences SA -56.06 Thousand EUR 152.287%
Plant Advanced Technologies SA 2.15 Million EUR 98.638%
Quantum Genomics Société Anonyme -1.41 Million EUR 102.065%
Sensorion SA 3.78 Million EUR 99.226%
Theranexus Société Anonyme -4.63 Million EUR 100.632%
TME Pharma N.V. -127 Thousand EUR 123.082%
Valbiotis SA 2.66 Million EUR 98.901%
TheraVet SA -530.79 Thousand EUR 105.523%
Valerio Therapeutics Société anonyme 1.26 Million EUR 97.686%
DBV Technologies S.A. 4.15 Million EUR 99.295%
Genfit S.A. 28.22 Million EUR 99.896%
GeNeuro SA -293.8 Thousand EUR 109.978%
Innate Pharma S.A. -4.12 Million EUR 100.711%
Inventiva S.A. 17.5 Million EUR 99.832%
MaaT Pharma SA 1.65 Million EUR 98.229%
MedinCell S.A. 9.28 Million EUR 99.684%
Nanobiotix S.A. 36.2 Million EUR 99.919%
OSE Immunotherapeutics SA 2.22 Million EUR 98.684%
Poxel S.A. 1000.00 EUR -2831.4%
GenSight Biologics S.A. 3 Million EUR 99.023%
Transgene SA -28.4 Million EUR 100.103%
Valneva SE 52.83 Million EUR 99.945%